MedAIDX is a neurodiagnostic pathology company providing advanced ENFD testing and digital diagnostic services nationwide.
MedAIDX has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
MedAIDX is headquartered in Austin, United States.
MedAIDX is a neurodiagnostic pathology company providing advanced ENFD testing and digital diagnostic services nationwide.
MedAIDX is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MedAIDX — Funding & Investors." VCBacked, May 18, 2026, https://www.vcbacked.co/company/medaidx. Accessed August 14, 2026.
VCBacked. (2026). MedAIDX — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/medaidx
{{cite web |title=MedAIDX — Funding & Investors |url=https://www.vcbacked.co/company/medaidx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated